Related Experiment Video
Updated: Apr 7, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Cardiovascular disease biomarkers across autoimmune diseases
Joseph Ahearn1, Kelly J Shields1, Chau-Ching Liu1
1Lupus Center of Excellence, Autoimmunity Institute, Department of Medicine, Allegheny Health Network, USA.
Insights
Patients with autoimmune disease face high risks of cardiovascular disease (CVD). New biomarkers help identify at-risk individuals for better prevention and treatment strategies.
Area of Science:
- Immunology
- Cardiology
- Biomarker Discovery
Background:
- Autoimmune diseases significantly increase the risk of premature cardiovascular disease (CVD) mortality.
- Early identification of high-risk patients with autoimmune disorders is crucial for timely intervention and prevention.
- Current diagnostic tools may not fully capture the complex CVD risk in these populations.
Purpose of the Study:
- To review recent advancements in cardiovascular disease biomarkers relevant to patients with autoimmune disorders.
- To highlight the potential clinical utility of these biomarkers for risk stratification and management.
- To discuss the role of biomarkers in accelerating targeted therapies for CVD in autoimmunity.
Main Methods:
- Literature review of recent studies on cardiovascular disease biomarkers in autoimmune diseases.
- Focus on lipid oxidation, imaging biomarkers (coronary calcium, plaque, intima media thickness), inflammation, complement, genetic, endothelial, and antiphospholipid antibody markers.
- Analysis of the clinical implementation and therapeutic implications of these biomarkers.
Main Results:
- Emerging biomarkers include lipid oxidation products, imaging assessments of atherosclerosis, inflammatory markers, complement activation products, genetic predispositions, endothelial dysfunction indicators, and antiphospholipid antibodies.
- These biomarkers offer a more comprehensive approach to assessing CVD risk in autoimmune disease.
- Successful clinical implementation can improve patient care and drug development.
Conclusions:
- A panel of diverse biomarkers is essential for accurate identification, monitoring, and stratification of cardiovascular risk in autoimmune disease patients.
- Implementing these biomarkers can enhance clinical decision-making and personalize treatment strategies.
- Further research and clinical validation will facilitate the reduction of cardiovascular mortality in individuals with autoimmune conditions.
Abstract:
Cardiovascular disease is increasingly recognized as a major cause of premature mortality among those with autoimmune disorders. There is an urgent need to identify those patients with autoimmune disease who are at risk for CVD so as to optimize therapeutic intervention and ultimately prevention. Accurate identification, monitoring and stratification of such patients will depend upon a panel of biomarkers of cardiovascular disease. This review will discuss some of the most recent biomarkers of cardiovascular diseases in autoimmune disease, including lipid oxidation, imaging biomarkers to characterize coronary calcium, plaque, and intima media thickness, biomarkers of inflammation and activated complement, genetic markers, endothelial biomarkers, and antiphospholipid antibodies. Clinical implementation of these biomarkers will not only enhance patient care but also likely accelerate the pharmaceutical pipeline for targeted intervention to reduce or eliminate cardiovascular disease in the setting of autoimmunity.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
07:20Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests